Refine Results
  1. "Harry Herr"
Formats
  1. Journal Article (484)
  2. Meeting Abstract (37)
  3. Conference Paper (15)
  4. Book Section (14)
  5. Editorial (5)
  6. Guidelines (3)
  7. Book Whole (1)
  8. Correspondence (1)
Groups
  1. Surgery (560)
  2. Urology (560)
  3. Department of Medicine (97)
  4. Solid Tumor Oncology Division (97)
  5. Genitourinary Oncology Service (95)
  6. Survivorship Research (53)

More Groups

People
  1. Harry Herr (560)
  2. Guido Dalbagni (113)
  3. Sherri Donat (107)
  4. Bernard Bochner (80)
  5. William Fair (70)
  6. Dean Bajorin (68)

More People

Years
  1. 2022 (4)
  2. 2021 (6)
  3. 2020 (11)
  4. 2019 (9)
  5. 2018 (12)
  6. 2017 (9)

More Years

Publications
  1. Journal of Urology (165)
  2. Journal of Clinical Oncology (56)
  3. Urology (50)
  4. European Urology (44)
  5. BJU International (43)
  6. Cancer (34)

More Publications

Publishers
  1. Elsevier Science, Inc. (261)
  2. Wiley Blackwell (89)
  3. American Society of Clinical Oncology (57)
  4. Elsevier Inc. (30)
  5. W.B. Saunders Co-Elsevier Inc. (13)
  6. Lippincott Williams & Wilkins (11)

More Publishers

Results (560)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Association of biochemically verified post-diagnosis smoking and nonmuscle-invasive bladder cancer recurrence risk
    Journal Article

    Furberg, H.; Petruzella, S.; Whiting, K.; Stein, E.; Orlow, I.; Kenney, J.; Corrales-Guerrero, S.; Benfante, N.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Urology (2022)

    Fulltext@MSK | Save
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Neoadjuvant atezolizumab with gemcitabine and cisplatin in patients with muscle-invasive bladder cancer: A multicenter, single-arm, phase II trial
    Journal Article

    Funt, S. A.; Lattanzi, M.; Whiting, K.; Al-Ahmadie, H.; Quinlan, C.; Teo, M. Y.; Lee, C. H.; Aggen, D.; Zimmerman, D.; McHugh, D.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Cisplatin, neoadjuvant chemotherapy and bladder cancer
    Journal Article

    Herr, H.; Soloway, M.
    Urology (2022)

    Fulltext@MSK | Save
  • Prospective phase II study to evaluate response to two induction courses (12 intravesical instillations) of BCG therapy for high-risk non–muscle-invasive bladder cancer
    Journal Article

    Herr, H.; Vertosick, E. A.; Dalbagni, G.; Cha, E. K.; Smith, R.; Benfante, N.; Sjoberg, D. D.; Sfakianos, J. P.
    Urology (2021)

    Fulltext@MSK | Save
  • Examining the accuracy of self-reported smoking-related exposure among recently diagnosed nonmuscle invasive bladder cancer patients
    Journal Article

    Petruzella, S.; Bochner, B. H.; Kenney, J.; Whiting, K.; Sadeghi, K.; Benfante, N.; Cha, E. K.; Dalbagni, G.; Donahue, T.; Donat, S. M.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save
  • A phase I trial of chemoimmunotherapy combining bacillus Calmette-Guerin (BCG) and intravesical gemcitabine for patients with BCG-relapsing high-grade nonmuscle-invasive bladder cancer
    Meeting Abstract

    De Jesus Escano, M. R.; Sjoberg, D. D.; McCarter, M.; McGill, M.; Goh, A.; Donahue, T. F.; Donat, M. S.; Cha, E. K.; Herr, H. W.; Meraney, A. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma
    Journal Article

    Teo, M. Y.; Al-Ahmadie, H.; Seier, K.; Tully, C.; Regazzi, A. M.; Pietzak, E.; Solit, D. B.; Tickoo, S.; Reuter, V.; Cha, E. K.; more...
    British Journal of Cancer (2021)

    Fulltext@MSK | Save
  • Improving the quality of transurethral resection of bladder tumor: Urologist, audit thyself
    Editorial

    Herr, H.
    European Urology Oncology (2021)

    Fulltext@MSK | Save
  • Electronic rapid fitness assessment identifies factors associated with adverse early postoperative outcomes following radical cystectomy
    Journal Article

    Chesnut, G. T.; Tin, A. L.; Sjoberg, D. D.; Jang, B.; Benfante, N.; Sarraf, S.; Herr, H.; Donat, S. M.; Dalbagni, G.; Bochner, B.; more...
    Journal of Urology (2021)

    Fulltext@MSK | Save